Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
AI Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
AI Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Foundayo
Pharma
The Oral GLP-1 Tracker: Prescriptions edge down
Fierce Pharma's weekly Oral GLP-1 Tracker monitors prescription trends for Novo Nordisk's Wegovy pill and Eli Lilly's Foundayo.
Angus Liu
,
Kevin Dunleavy
,
Fraiser Kansteiner
,
Donavyn Coffey
Oct 9, 2026 1:48pm
Lilly dives deep into Foundayo's cardio perks in T2D, obesity
Oct 1, 2026 11:38am
Novo, Lilly unleash dueling GLP-1 datasets at EASD in Milan
Sep 29, 2026 11:20am
Eli Lilly blasted for ‘emotive’ language in GLP-1 press release
Sep 25, 2026 9:01am
Lilly captures 70% of surging Medicare GLP-1 market, CEO says
Sep 23, 2026 10:55am
No more Nordisk as Novo goes it alone amid rebranding push
Sep 14, 2026 6:54am
